FGF-23 and Endothelial Dysfunction in Diabetic Proteinuric Patients

Summary

There is no data about the effects of Renin angiotensin system blockage (RAS) on FGF23 and ADMA levels in diabetic patients with proteinuria. The aim of this study was to find out whether the beneficial effects of RAS blockage in diabetic proteinuria has any relation with the alteration of ADMA and FGF-23 levels. We searched for the effects of ACE inhibitor ramipril on the clinical and laboratory parameters of diabetic patients with proteinuria.

Timeline

Start

2008-01

Primary completion

2009-03

Completion

2009-04

Drugs

Indications